G-code: Procedures and professional services (temporary) Procedures and professional services (temporary)
2,011 codes
Billing context
G-codes are temporary codes for professional services and procedures that would otherwise be coded in CPT.
| Code | Long descriptor | Payment limit (Q4 2026) | Added | Status |
|---|---|---|---|---|
| G9555 | Documentation of medical reason(s) for recommending follow up imaging (e.g., patient has multiple endocrine neoplasia, patient has cervical lymphadenopathy, other medical reason(s)) | — | Jan 1, 2016 | Active |
| G9556 | Final reports for ct, cta, mri or mra of the chest or neck with follow-up imaging not recommended | — | Jan 1, 2016 | Active |
| G9557 | Final reports for ct, cta, mri or mra studies of the chest or neck without an incidentally found thyroid nodule < 1.0 cm noted or no nodule found | — | Jan 1, 2016 | Active |
| G9558 | Patient treated with a beta-lactam antibiotic as definitive therapy | — | Jan 1, 2016 | Ended Dec 31, 2020 |
| G9559 | Documentation of medical reason(s) for not prescribing a beta-lactam antibiotic (e.g., allergy, intolerance to beta-lactam antibiotics) | — | Jan 1, 2016 | Ended Dec 31, 2020 |
| G9560 | Patient not treated with a beta-lactam antibiotic as definitive therapy, reason not given | — | Jan 1, 2016 | Ended Dec 31, 2020 |
| G9561 | Patients prescribed opiates for longer than six weeks | — | Jan 1, 2016 | Ended Dec 31, 2021 |
| G9562 | Patients who had a follow-up evaluation conducted at least every three months during opioid therapy | — | Jan 1, 2016 | Ended Dec 31, 2021 |
| G9563 | Patients who did not have a follow-up evaluation conducted at least every three months during opioid therapy | — | Jan 1, 2016 | Ended Dec 31, 2021 |
| G9572 | Index date phq-score greater than 9 documented during the twelve month denominator identification period | — | Jan 1, 2016 | Ended Dec 31, 2016 |
| G9573 | Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five | — | Jan 1, 2016 | Ended Dec 31, 2020 |
| G9574 | Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five; either phq-9 or phq-9m score was not assessed or is greater than or equal to five | — | Jan 1, 2016 | Ended Dec 31, 2020 |
| G9577 | Patients prescribed opiates for longer than six weeks | — | Jan 1, 2016 | Ended Dec 31, 2021 |
| G9578 | Documentation of signed opioid treatment agreement at least once during opioid therapy | — | Jan 1, 2016 | Ended Dec 31, 2021 |
| G9579 | No documentation of signed an opioid treatment agreement at least once during opioid therapy | — | Jan 1, 2016 | Ended Dec 31, 2021 |
| G9580 | Door to puncture time of 90 minutes or less | — | Jan 1, 2016 | Active |
| G9581 | Door to puncture time of greater than 2 hours for reasons documented by clinician (e.g., patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatment; hospitalized patients with newly diagnosed cva considered for endovascular stroke treatment) | — | Jan 1, 2016 | Ended Dec 31, 2016 |
| G9582 | Door to puncture time of greater than 90 minutes, no reason given | — | Jan 1, 2016 | Active |
| G9583 | Patients prescribed opiates for longer than six weeks | — | Jan 1, 2016 | Ended Dec 31, 2021 |
| G9584 | Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy | — | Jan 1, 2016 | Ended Dec 31, 2021 |
| G9585 | Patient not evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient not interviewed at least once during opioid therapy | — | Jan 1, 2016 | Ended Dec 31, 2021 |
| G9593 | Pediatric patient with minor blunt head trauma classified as low risk according to the pecarn prediction rules | — | Jan 1, 2016 | Active |
| G9594 | Patient presented with a minor blunt head trauma and had a head ct ordered for trauma by an emergency care provider | — | Jan 1, 2016 | Active |
| G9595 | Patient has documentation of ventricular shunt, brain tumor, or coagulopathy | — | Jan 1, 2016 | Active |
| G9596 | Pediatric patient had a head ct for trauma ordered by someone other than an emergency care provider or was ordered for a reason other than trauma | — | Jan 1, 2016 | Ended Dec 31, 2023 |
| G9597 | Pediatric patient with minor blunt head trauma not classified as low risk according to the pecarn prediction rules | — | Jan 1, 2016 | Active |
| G9598 | Aortic aneurysm 5.5 - 5.9 cm maximum diameter on centerline formatted ct or minor diameter on axial formatted ct | — | Jan 1, 2016 | Active |
| G9599 | Aortic aneurysm 6.0 cm or greater maximum diameter on centerline formatted ct or minor diameter on axial formatted ct | — | Jan 1, 2016 | Active |
| G9600 | Symptomatic aaas that required urgent/emergent (non-elective) repair | — | Jan 1, 2016 | Ended Dec 31, 2020 |
| G9601 | Patient discharge to home no later than post-operative day #7 | — | Jan 1, 2016 | Ended Dec 31, 2020 |
| G9602 | Patient not discharged to home by post-operative day #7 | — | Jan 1, 2016 | Ended Dec 31, 2020 |
| G9603 | Patient survey score improved from baseline following treatment | — | Jan 1, 2016 | Active |
| G9604 | Patient survey results not available | — | Jan 1, 2016 | Ended Dec 31, 2025 |
| G9605 | Patient survey score did not improve from baseline following treatment | — | Jan 1, 2016 | Active |
| G9606 | Intraoperative cystoscopy performed to evaluate for lower tract injury | — | Jan 1, 2016 | Active |
| G9607 | Documented medical reasons for not performing intraoperative cystoscopy (e.g., urethral pathology precluding cystoscopy, any patient who has a congenital or acquired absence of the urethra) or in the case of patient death | — | Jan 1, 2016 | Active |
| G9608 | Intraoperative cystoscopy not performed to evaluate for lower tract injury | — | Jan 1, 2016 | Active |
| G9609 | Documentation of an order for anti-platelet agents | — | Jan 1, 2016 | Active |
| G9610 | Documentation of medical reason(s) in the patient's record for not ordering anti-platelet agents | — | Jan 1, 2016 | Active |
| G9611 | Order for anti-platelet agents was not documented in the patient's record, reason not given | — | Jan 1, 2016 | Active |
| G9612 | Photodocumentation of two or more cecal landmarks to establish a complete examination | — | Jan 1, 2016 | Ended Dec 31, 2023 |
| G9613 | Documentation of post-surgical anatomy (e.g., right hemicolectomy, ileocecal resection, etc.) | — | Jan 1, 2016 | Ended Dec 31, 2023 |
| G9614 | Photodocumentation of less than two cecal landmarks (i.e., no cecal landmarks or only one cecal landmark) to establish a complete examination | — | Jan 1, 2016 | Ended Dec 31, 2023 |
| G9615 | Preoperative assessment documented | — | Jan 1, 2016 | Ended Dec 31, 2020 |
| G9616 | Documentation of reason(s) for not documenting a preoperative assessment (e.g., patient with a gynecologic or other pelvic malignancy noted at the time of surgery) | — | Jan 1, 2016 | Ended Dec 31, 2020 |
| G9617 | Preoperative assessment not documented, reason not given | — | Jan 1, 2016 | Ended Dec 31, 2020 |
| G9618 | Documentation of screening for uterine malignancy or those that had an ultrasound and/or endometrial sampling of any kind | — | Jan 1, 2016 | Ended Dec 31, 2022 |
| G9619 | Documentation of reason(s) for not screening for uterine malignancy (e.g., prior hysterectomy) | — | Jan 1, 2016 | Ended Dec 31, 2016 |
| G9620 | Patient not screened for uterine malignancy, or those that have not had an ultrasound and/or endometrial sampling of any kind, reason not given | — | Jan 1, 2016 | Ended Dec 31, 2022 |
| G9621 | Patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method and received brief counseling | — | Jan 1, 2016 | Active |
| G9622 | Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method | — | Jan 1, 2016 | Active |
| G9623 | Documentation of medical reason(s) for not screening for unhealthy alcohol use (e.g., limited life expectancy, other medical reasons) | — | Jan 1, 2016 | Ended Dec 31, 2022 |
| G9624 | Patient not screened for unhealthy alcohol use using a systematic screening method or patient did not receive brief counseling if identified as an unhealthy alcohol user | — | Jan 1, 2016 | Active |
| G9625 | Patient sustained bladder injury at the time of surgery or discovered subsequently up to 30 days post-surgery | — | Jan 1, 2016 | Active |
| G9626 | Documented medical reason for not reporting bladder injury (e.g., gynecologic or other pelvic malignancy documented, concurrent surgery involving bladder pathology, injury that occurs during a urinary incontinence procedure, patient death from non-medical causes not related to surgery, patient died during procedure without evidence of bladder injury) | — | Jan 1, 2016 | Active |
| G9627 | Patient did not sustain bladder injury at the time of surgery nor discovered subsequently up to 30 days post-surgery | — | Jan 1, 2016 | Active |
| G9628 | Patient sustained bowel injury at the time of surgery or discovered subsequently up to 30 days post-surgery | — | Jan 1, 2016 | Active |
| G9629 | Documented medical reasons for not reporting bowel injury (e.g., gynecologic or other pelvic malignancy documented, planned (e.g., not due to an unexpected bowel injury) resection and/or re-anastomosis of bowel, or patient death from non-medical causes not related to surgery, patient died during procedure without evidence of bowel injury) | — | Jan 1, 2016 | Active |
| G9630 | Patient did not sustain a bowel injury at the time of surgery nor discovered subsequently up to 30 days post-surgery | — | Jan 1, 2016 | Active |
| G9631 | Patient sustained ureter injury at the time of surgery or discovered subsequently up to 30 days post-surgery | — | Jan 1, 2016 | Ended Dec 31, 2022 |
| G9632 | Documented medical reasons for not reporting ureter injury (e.g., gynecologic or other pelvic malignancy documented, concurrent surgery involving bladder pathology, injury that occurs during a urinary incontinence procedure, patient death from non-medical causes not related to surgery, patient died during procedure without evidence of ureter injury) | — | Jan 1, 2016 | Ended Dec 31, 2022 |
| G9633 | Patient did not sustain ureter injury at the time of surgery nor discovered subsequently up to 30 days post-surgery | — | Jan 1, 2016 | Ended Dec 31, 2022 |
| G9634 | Health-related quality of life assessed with tool during at least two visits and quality of life score remained the same or improved | — | Jan 1, 2016 | Ended Dec 31, 2021 |
| G9635 | Health-related quality of life not assessed with tool for documented reason(s) (e.g., patient has a cognitive or neuropsychiatric impairment that impairs his/her ability to complete the hrqol survey, patient has the inability to read and/or write in order to complete the hrqol questionnaire) | — | Jan 1, 2016 | Ended Dec 31, 2021 |
| G9636 | Health-related quality of life not assessed with tool during at least two visits or quality of life score declined | — | Jan 1, 2016 | Ended Dec 31, 2021 |
| G9637 | Final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique) | — | Jan 1, 2016 | Active |
| G9638 | Final reports without documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique) | — | Jan 1, 2016 | Active |
| G9639 | Major amputation or open surgical bypass not required within 48 hours of the index endovascular lower extremity revascularization procedure | — | Jan 1, 2016 | Ended Dec 31, 2021 |
| G9640 | Documentation of planned hybrid or staged procedure | — | Jan 1, 2016 | Ended Dec 31, 2021 |
| G9641 | Major amputation or open surgical bypass required within 48 hours of the index endovascular lower extremity revascularization procedure | — | Jan 1, 2016 | Ended Dec 31, 2021 |
| G9642 | Current smoker (e.g., cigarette, cigar, pipe, e-cigarette or marijuana) | — | Jan 1, 2016 | Active |
| G9643 | Elective surgery | — | Jan 1, 2016 | Active |
| G9644 | Patients who abstained from smoking prior to anesthesia on the day of surgery or procedure | — | Jan 1, 2016 | Active |
| G9645 | Patients who did not abstain from smoking prior to anesthesia on the day of surgery or procedure | — | Jan 1, 2016 | Active |
| G9646 | Patients with 90 day mrs score of 0 to 2 | — | Jan 1, 2016 | Active |
| G9647 | Patients in whom mrs score could not be obtained at 90 day follow-up | — | Jan 1, 2016 | Ended Dec 31, 2021 |
| G9648 | Patients with 90 day mrs score greater than 2 | — | Jan 1, 2016 | Active |
| G9649 | Psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi)) | — | Jan 1, 2016 | Active |
| G9650 | Documentation that the patient declined therapy change or has documented contraindications (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi | — | Jan 1, 2016 | Ended Dec 31, 2016 |
| G9651 | Psoriasis assessment tool documented not meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi)) or psoriasis assessment tool not documented | — | Jan 1, 2016 | Active |
| G9652 | Patient has been treated with a systemic or biologic medication for psoriasis for at least six months | — | Jan 1, 2016 | Ended Dec 31, 2016 |
| G9653 | Patient has not been treated with a systemic or biologic medication for psoriasis for at least six months | — | Jan 1, 2016 | Ended Dec 31, 2016 |
| G9654 | Monitored anesthesia care (mac) | — | Jan 1, 2016 | Active |
| G9655 | A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used | — | Jan 1, 2016 | Active |
| G9656 | Patient transferred directly from anesthetizing location to pacu or other non-icu location | — | Jan 1, 2016 | Active |
| G9657 | Transfer of care during an anesthetic or to the intensive care unit | — | Jan 1, 2016 | Ended Dec 31, 2016 |
| G9658 | A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is not used | — | Jan 1, 2016 | Active |
| G9659 | Patients greater than or equal to 86 years of age who underwent a screening colonoscopy and did not have a history of colorectal cancer or other valid medical reason for the colonoscopy, including: iron deficiency anemia, lower gastrointestinal bleeding, familial adenomatous polyposis, lynch syndrome (i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel disease (i.e., crohn's disease or ulcerative colitis), abnormal finding of gastrointestinal tract, weight loss, or changes in bowel habits | — | Jan 1, 2016 | Active |
| G9660 | Documentation of medical reason(s) for a colonoscopy performed on a patient greater than or equal to 86 years of age (e.g., iron deficiency anemia, lower gastrointestinal bleeding, familial history of adenomatous polyposis, lynch syndrome (i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel disease (i.e., crohn's disease or ulcerative colitis), abnormal finding of gastrointestinal tract, weight loss, or changes in bowel habits) | — | Jan 1, 2016 | Active |
| G9661 | Patients greater than or equal to 86 years of age who received a colonoscopy for an assessment of signs/symptoms of gi tract illness, and/or because the patient meets high risk criteria, and/or to follow-up on previously diagnosed advanced lesions | — | Jan 1, 2016 | Active |
| G9662 | Previously diagnosed or have a diagnosis of clinical ascvd, including ascvd procedure | — | Jan 1, 2016 | Active |
| G9663 | Any ldl-c laboratory result >= 190 mg/dl | — | Jan 1, 2016 | Active |
| G9664 | Patients who are currently statin therapy users or received an order (prescription) for statin therapy | — | Jan 1, 2016 | Active |
| G9665 | Patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy | — | Jan 1, 2016 | Active |
| G9666 | Patient's highest fasting or direct ldl-c laboratory test result in the measurement period or two years prior to the beginning of the measurement period is 70-189 mg/dl | — | Jan 1, 2016 | Ended Dec 31, 2021 |
| G9667 | Documentation of medical reason(s) for not currently being a statin therapy user or receive an order (prescription) for statin therapy (e.g., patient with adverse effect, allergy or intolerance to statin medication therapy, patients who have an active diagnosis of pregnancy or who are breastfeeding, patients who are receiving palliative care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease (esrd), and patients with diabetes who have a fasting or direct ldl-c laboratory test result < 70 mg/dl and are not taking statin therapy) | — | Jan 1, 2016 | Ended Dec 31, 2016 |
| G9669 | I intend to report the multiple chronic conditions measures group | — | Jan 1, 2016 | Ended Dec 31, 2016 |
| G9670 | All quality actions for the applicable measures in the multiple chronic conditions measures group have been performed for this patient | — | Jan 1, 2016 | Ended Dec 31, 2016 |
| G9671 | I intend to report the diabetic retinopathy measures group | — | Jan 1, 2016 | Ended Dec 31, 2016 |
| G9672 | All quality actions for the applicable measures in the diabetic retinopathy measures group have been performed for this patient | — | Jan 1, 2016 | Ended Dec 31, 2016 |